marijuana stocks news

Plandaí Biotechnology, Inc. (PLPL)

 

Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014
Total Revenue 127   26   15   11  
Cost of Revenue 247 160 207 140
Gross Profit (120) (134) (192) (129)
Operating Expenses
Research Development (83) 83
Selling General and Administrative 755 1,294 3,163 2,661
Non Recurring
Others 46 46 46 44
Total Operating Expenses
Operating Income or Loss (922) (1,474) (3,318) (2,917)
Income from Continuing Operations
Total Other Income/Expenses Net (200) 981 (4,973)
Earnings Before Interest And Taxes (1,121) (493) (8,291) (2,917)
Interest Expense 133 118 147 135
Income Before Tax (1,254) (611) (8,437) (3,052)
Income Tax Expense
Minority Interest 99 (27) 44 81
Net Income From Continuing Ops (1,155) (638) (8,393) (2,971)
Non-recurring Events
Discontinued Operations
Extraordinary Items
Effect Of Accounting Changes
Other Items
Net Income (1,155) (638) (8,393) (2,971)
Preferred Stock And Other Adjustments
Net Income Applicable To Common Shares (1,155) (638) (8,393) (2,971)

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Reliq Health Technologies Inc. (RQHTF) Announces Expansion of Paz Home Health Contract by 5,000 New Patients

Reliq Health Technologies Announces Expansion of Paz Home Health Contract by 5,000…

$TAUG Provides Update on Status of its Lawsuit

Tauriga Sciences, Inc. Provides Update on Status of its Lawsuit Against Cowan…

GrowLife, Inc. (PHOT) Adds Los Angeles Retail and West Coast Fulfillment Center

GrowLife, Inc. Adds Los Angeles Retail and West Coast Fulfillment Center to…

$NVLX Gets FDA Orphan Drug Designation

FDA Grants Orphan Drug Designation to Nuvilex for Pancreatic Cancer Treatment SILVER…